Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03947242
Status:
UNKNOWN
Last Update Posted:
2019-05-15
First Post:
2019-05-09
Brief Title:
Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2 Positive Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Trastuzumab-refractory | View |